Pilot Testing an Asynchronous Online Harm Reduction and Pharmacotherapy Stigma Reduction Training for Substance Use Treatment Professionals

Harm reduction and pharmacotherapy approaches to addressing substance use disorder are evidence-based practices for reducing adverse health outcomes. However, professional stigma toward these approaches impedes implementation. In this pilot study, professionals working in substance use treatment ser...

Ausführliche Beschreibung

Gespeichert in:  
Bibliographische Detailangaben
VerfasserInnen: Sulzer, Sandra H. (VerfasserIn) ; Prevedel, Suzanne (VerfasserIn) ; Barrett, Tyson S. (VerfasserIn) ; Mekjian, Margo (VerfasserIn) ; Vincent, Mindy (VerfasserIn) ; Frabis, Felicia (VerfasserIn) ; Meier, Cris (VerfasserIn) ; Shiverdecker, Claire Warnick (VerfasserIn) ; Voss, Maren Wright (VerfasserIn) ; Cook, Paula J. (VerfasserIn) ; Madden, Erin Fanning (VerfasserIn)
Medienart: Elektronisch Aufsatz
Sprache:Englisch
Veröffentlicht: 2025
In: Journal of drug issues
Jahr: 2025, Band: 55, Heft: 3, Seiten: 327-339
Online-Zugang: Vermutlich kostenfreier Zugang
Volltext (lizenzpflichtig)
Journals Online & Print:
Lade...
Verfügbarkeit prüfen: HBZ Gateway
Schlagwörter:
online learning
Education
Naloxone
overdose prevention sites
Harm Reduction
treatment professionals
Buprenorphine
methadone
medications for opioid use disorder
Stigma
Beschreibung
Zusammenfassung:Harm reduction and pharmacotherapy approaches to addressing substance use disorder are evidence-based practices for reducing adverse health outcomes. However, professional stigma toward these approaches impedes implementation. In this pilot study, professionals working in substance use treatment services received a 4-hour asynchronous online harm reduction and pharmacotherapy training. Pre- and post-training surveys used Likert-scale questions to assess attitudes and planned actions. Four of the 23 survey items demonstrated a significant change in pre- to post-attitudes and planned actions relating to harm reduction or pharmacotherapy. These items included less attitudinal stigma towards: methadone and buprenorphine (p = .021), overdose prevention sites/“drug consumption facilities” (p = .025), and naloxone distribution (p = .017), as well as lower intent to primarily promote abstinence-based interventions (p = .007). This study demonstrated that online asynchronous educational interventions show promise for reducing stigmatizing attitudes towards evidence-based practices among substance use treatment professionals.
ISSN:1945-1369
DOI:10.1177/00220426231226223